0000912282-25-000823.txt : 20250805 0000912282-25-000823.hdr.sgml : 20250805 20250805171436 ACCESSION NUMBER: 0000912282-25-000823 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250801 FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schreiber Justin CENTRAL INDEX KEY: 0001720512 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 251186169 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 form4.xml X0508 4 2025-08-01 0000948320 LifeMD, Inc. LFMD 0001720512 Schreiber Justin 236 FIFTH AVENUE, SUITE 400 NEW YORK NY 10001 true true Chairman and CEO true Common Stock 2025-07-01 4 S 0 25000 9.9876 D 2475721 I by Schreiber Holdings LLC Common Stock 200000 D Common Stock 13997 I By Child 1 Common Stick 13997 I By Child 2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 and $10.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above. /s/ Justin Schreiber 2025-08-05